Hims & Hers Health
HIMS
436 hedge funds and large institutions have $3.1B invested in Hims & Hers Health in 2026 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 158 increasing their positions, 142 reducing their positions, and 127 closing their positions.
27% more call options, than puts
Call options by funds: $854M | Put options by funds: $673M
11% more repeat investments, than reductions
Existing positions increased: 158 | Existing positions reduced: 142
10% less funds holding
Funds holding: 486 → 436 (-50)
15.57% less ownership
Funds ownership: 83.59% → 68.02% (-16%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
34% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 127
48% less capital invested
Capital invested by funds: $5.96B → $3.1B (-$2.86B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DE
Defiance ETFs
New York
|
+$175M |
| 2 |
Morgan Stanley
New York
|
+$117M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$68M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$33.5M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$33.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$465M |
| 2 |
JP Morgan Chase
New York
|
-$321M |
| 3 |
Goldman Sachs
New York
|
-$186M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$79.8M |
| 5 |
Renaissance Technologies
New York
|
-$63.8M |
HIMS Hedge Fund Activity: Q1 2026 in Review
436 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q1 2026, worth a combined $3.1B — down 48% from $5.96B a quarter earlier.
Sellers outnumbered buyers: 127 funds closed out of HIMS and 84 opened new positions — a net loss of 43 holders — while 142 trimmed existing stakes and 158 added.
The largest buyer was Defiance ETFs, opening a new position worth an estimated $175M. The largest seller was Capital World Investors, exiting entirely with an estimated $465M sold.
- 436 institutional investors held Hims & Hers Health (HIMS) as of Q1 2026, down from 486 in Q4 2025.
- Funds reported $3.1B of Hims & Hers Health stock for Q1 2026, down 48% quarter-over-quarter.
- 84 funds opened new Hims & Hers Health positions in Q1 2026 and 127 closed out, a net change of -43 holders.
- The largest Hims & Hers Health buyer in Q1 2026 was Defiance ETFs, an estimated $175M added.
- The largest Hims & Hers Health seller in Q1 2026 was Capital World Investors, an estimated $465M sold.
Based on aggregated 13F filings for Q1 2026.